ONCT · Categories · 8-K

ONCT - SEC Form 8-K filings

Oncternal Therapeutics Inc. (ONCT) sec form 8-k filings - real-time wire coverage filtered to 8-K only.

Recent 8-K for ONCT

556d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
566d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Leadership Update
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
629d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Leadership Update, Other Events
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
664d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
712d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
755d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
818d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
862d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
880d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
937d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
971d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
993d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders (Amendment)
8-K/A - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1028d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1071d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1097d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Leadership Update
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1126d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1154d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1157d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Other Events
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1175d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Leadership Update (Amendment)
8-K/A - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1182d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1233d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition (Amendment)
8-K/A - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1244d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1246d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Leadership Update
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1258d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Leadership Update
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1270d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Other Events
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1308d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1339d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1373d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Other Events
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1447d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1469d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Other Events
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1513d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1546d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1590d
Oncternal Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1629d
Oncternal Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1633d
Oncternal Therapeutics, Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1672d
Oncternal Therapeutics, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1763d
Oncternal Therapeutics, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1809d
Oncternal Therapeutics, Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1832d
SEC Form 8-K filed by Oncternal Therapeutics, Inc.
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1841d
Oncternal Therapeutics, Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1854d
Oncternal Therapeutics, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)
1899d
SEC Form 8-K filed by Oncternal Therapeutics, Inc.
8-K - Oncternal Therapeutics, Inc. (0001260990) (Filer)

ONCT - SEC Form 8-K filings

Recent 8-K for ONCT

Other ONCT categories